EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exame citológico versus teste de DNA-HPV: revisão de literatura sobre métodos de rastreamento do câncer do colo do útero nas perspectivas atuais

Soelley Duarte Alves da Silva, Carlos Murilo Lopes, Divonete Ursulino da Silva, Marilene Duarte de Araújo, Conceição Adriane Nóbrega de Mendonça, Severina Ramos Nóbrega de Mendonça, Jane Pereira da Silva, Osani Barbosa Machado, Ednalva Gomes Oliveira da Silva, Claudiomar Angelo Gomes Sampaio, Yara Cecy Araujo Veloso, Eduardo Paulo Queiroz

Revista ft · 21.08.2026 · 30 (161) · 01-20

DOI: 10.69849/wb10e427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 21.08.2026. Verfasst von Soelley Duarte Alves da Silva und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Cervical cancer is a prevalent malignancy in Brazil, primarily caused by persistent infection with high-risk Human Papillomavirus (HPV). OBJECTIVE: This review synthesized evidence regarding the diagnostic accuracy of conventional cytology compared to HPV-DNA testing, supporting the transition to molecular screening in Brazilian guidelines. MATERIALS AND METHODS: A systematic search was conducted in MEDLINE, LILACS, and SCOPUS for studies published between 2015 and 2025, analyzing 17 selected investigations. RESULTS: Data show the superiority of HPV-DNA testing, with sensitivity between 92% and 98.1% for high-grade lesions (CIN 2+ and CIN 3+), compared to 48.5%–73.3% for cytology. The molecular test showed a negative predictive value close to 100%, allowing for safe five-year intervals. Brazilian studies indicated that HPV-DNA screening detects lesions approximately ten years earlier than the cytological model. FINAL CONSIDERATIONS: Replacing cytology with HPV-DNA testing represents a significant public health advancement, providing better early intervention and reducing mortality. In conclusion, the molecular method is more effective and secure, aligning Brazil with international oncological control standards and ensuring greater health system efficiency.

Zitieren

APA

Silva, S. D. A. D., Lopes, C. M., Silva, D. U. D., Araújo, M. D. D., Mendonça, C. A. N. D., Mendonça, S. R. N. D., Silva, J. P. D., Machado, O. B., Silva, E. G. O. D., Sampaio, C. A. G., Veloso, Y. C. A., & Queiroz, E. P. (2026). Exame citológico versus teste de DNA-HPV: revisão de literatura sobre métodos de rastreamento do câncer do colo do útero nas perspectivas atuais. Revista ft, 30(161), 01-20. https://doi.org/10.69849/wb10e427

Vancouver

Silva SDAD, Lopes CM, Silva DUD, Araújo MDD, Mendonça CAND, Mendonça SRND, et al. Exame citológico versus teste de DNA-HPV: revisão de literatura sobre métodos de rastreamento do câncer do colo do útero nas perspectivas atuais. Revista ft. 2026;30(161):01-20. doi:10.69849/wb10e427

BibTeX
@article{Silva2026,
  author = {Silva, Soelley Duarte Alves da and Lopes, Carlos Murilo and Silva, Divonete Ursulino da and Araújo, Marilene Duarte de and Mendonça, Conceição Adriane Nóbrega de and Mendonça, Severina Ramos Nóbrega de and Silva, Jane Pereira da and Machado, Osani Barbosa and Silva, Ednalva Gomes Oliveira da and Sampaio, Claudiomar Angelo Gomes and Veloso, Yara Cecy Araujo and Queiroz, Eduardo Paulo},
  title = {Exame citológico versus teste de DNA-HPV: revisão de literatura sobre métodos de rastreamento do câncer do colo do útero nas perspectivas atuais},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {161},
  pages = {01--20},
  doi = {10.69849/wb10e427}
}
Kostenlos starten →